Sixty Degree Capital

Activity from announced rounds

Activity in this selectionSeries C+
Rounds participated in
3
Confirmed lead rounds
—
3 roles undisclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$353M
3 disclosed · full round size, not this investor’s share

By stage

Series C+3

By primary sector

Biotech1
Cybersecurity1
Defense tech1

By country

United States3

Rounds

3 in this selection
Eclypsium

Provides supply chain security for IT infrastructure

$25MSeries C+
Role not disclosed
HawkEye 360

Detects, geolocates, and characterizes RF signals using a commercial satellite constellation

$23MSeries E
Role not disclosed
Parabilis Medicines

Develops medicines targeting historically undruggable protein targets in cancer

$305MSeries F
Role not disclosed